Annual Outcomes With Transcatheter Valve Therapy: From the STS/ACC TVT Registry

Annals of Thoracic Surgery

Volumn 101, Issue 2, 2016, Pages 789-800

  Holmes, David R ^a   Nishimura, Rick A ^a   Grover, Frederick L ^b   Brindis, Ralph G ^c   Carroll, John D ^b   Edwards, Fred H ^d   Peterson, Eric D ^e   Rumsfeld, John S ^f   Shahian, David M ^g   Thourani, Vinod H ^h   Tuzcu, E Murat ⁱ   Vemulapalli, Sreekanth ^e   Hewitt, Kathleen ^j   Michaels, Joan ^j   Fitzgerald, Susan ^j   Mack, Michael J ^k  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h EMORY UNIVERSITY   (United States)

ⁱ LERNER RESEARCH INSTITUTE   (United States)

^j AMERICAN COLLEGE OF CARDIOLOGY   (United States)

^k SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; CARDIOLOGY; FEMALE; HEART CATHETERIZATION; HEART VALVE REPLACEMENT; HUMAN; MALE; MEDICAL SOCIETY; OUTCOME ASSESSMENT; PROCEDURES; REGISTER; TRANSCATHETER AORTIC VALVE IMPLANTATION; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARDIAC CATHETERIZATION; CARDIOLOGY; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); REGISTRIES; SOCIETIES, MEDICAL; TRANSCATHETER AORTIC VALVE REPLACEMENT; UNITED STATES;

EID: 85027922160     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2015.10.049     Document Type: Article

References (22)

1. Carroll, J.D., Edwards, F.H., Marinac-Dabic, D., et al. The STS-ACC Transcatheter Valve Therapy National Registry: a new partnership and infrastructure for the introduction and surveillance of medical devices and therapies. J Am Coll Cardiol 62 (2013), 1026–1034.
2. Rumsfeld, J.S., Holmes, D.R. Jr., Stough, W.G., et al. Insights from the early experience of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. J Am Coll Cardiol Intv 8 (2015), 377–381.
3. Carroll, J.D., Shuren, J., Jensen, T.S., et al. Transcatheter valve therapy registry is a model for medical device innovation and surveillance. Health Aff (Millwood) 34 (2015), 328–334.
4. Mack, M.J., Holmes, D.R. Jr., Rational dispersion for the introduction of transcatheter valve therapy. JAMA 306 (2011), 2149–2150.
5. Sedrakyan, A., Marinac-Dabic, D., Holmes, D.R., The international registry infrastructure for cardiovascular device evaluation and surveillance. JAMA 310 (2013), 257–259.
6. Center for Devices and Radiological Health, U.S. Food and Drug Administration. Strengthening our national system for medical device postmarket surveillance: update and next steps. 2013. Available at: http://www.fda.gov/downloads/MedicalDevices/Safety/CDRHPostmarketSurveillance/UCM348845.pdf. Accessed October 15, 2015.
7. Mack, M.J., Brennan, J.M., Brindis, R.G., et al., for the STS/ACC TVT Registry. Outcomes following transcatheter aortic valve replacement in the United States. JAMA 310 (2013), 2069–2077.
8. Brennan, J.M., Holmes, D.R., Sherwood, M.W., et al. The association of transcatheter aortic valve replacement availability and hospital aortic valve replacement volume and mortality in the United States. Ann Thorac Surg 98 (2014), 2016–2022 discussion 2022.
9. Holmes, D.R. Jr., Brennan, M., Rumsfeld, J.S., et al., for the STS/ACC TVT Registry. Clinical outcomes at 1 year following transcatheter aortic valve replacement. JAMA 313 (2015), 1019–1028.
10. Leon, M.B., Piazza, N., Nikolsky, E., et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol 57 (2011), 253–269.
11. Kappetein, A.P., Head, S.J., Généreux, P., et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol 60 (2012), 1438–1454.
12. Green, C.P., Porter, C.B., Bresnahan, D.R., et al. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol 35 (2000), 1245–1255.
13. Arnold, S.V., Spertus, J.A., Lei, Y., et al. Use of the Kansas City Cardiomyopathy Questionnaire for monitoring health status in patients with aortic stenosis. Circ Heart Fail 6 (2013), 61–67.
14. Dewey, T.M., Brown, D., Ryan, W.H., et al. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg 135 (2008), 180–187.
15. Barbanti, M., Binder, R.K., Freeman, M., et al. Impact of low-profile sheaths on vascular complications during transfemoral transcatheter aortic valve replacement. EuroIntervention 9 (2013), 929–935.
16. Van Mieghem, N.M., Généreux, P., van der Boon, R.M., et al. Transcatheter aortic valve replacement and vascular complications definitions. EuroIntervention 9 (2014), 1317–1322.
17. Latsios, G., Gerckens, U., Buellesfeld, L., et al. “Device landing zone” calcification, assessed by MSCT, as a predictive factor for pacemaker implantation after TAVI. Catheter Cardiovasc Interv 76 (2010), 431–439.
18. Tchetche, D., Modine, T., Farah, B., et al. Update on the need for a permanent pacemaker after transcatheter aortic valve implantation using the CoreValve Accutrak system. EuroIntervention 8 (2012), 556–562.
19. van der Boon, R.M., Van Mieghem, N.M., Theuns, D.A., et al. Pacemaker dependency after transcatheter aortic valve implantation with the self-expanding Medtronic Core Valve system. Int J Cardiol 168 (2013), 1269–1273.
20. Bleiziffer, S., Ruge, H., Hörer, J., et al. Predictors for new-onset complete heart block after transcatheter aortic valve implantation. J Am Coll Cardiol Intv 3 (2010), 524–530.
21. Nishimura, R.A., Otto, C.M., Bonow, R.O., et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63 (2014), 2438–2488.
22. Husten L. Using registry data, FDA expands indication for Edwards’ Sapien Transcatheter Heart Valves. Forbes. September 23, 2013. Available at: http://www.forbes.com/sites/larryhusten/2013/09/23/using-registry-data-fda-expands-indication-for-edwards-sapien-transcatheter-heart-valves/. Accessed October 15, 2015.